ClinicalTrials.govpublic full text
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
hepatocellular carcinoma, pembrolizumab, y90 radioembolization, keytruda®, therasphere®, pd-1, igg4/kappa isotype, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846917
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.